Chest
Treatment Patterns in Patients With Incident Pulmonary Hypertension: Real-World Data From the Pulmonary Hypertension Association Registry.
Sarah L Khan, Carly J Paoli, Noah Kime, Kayleen Williams, Gabriela Gomez Rendon, Adriano R Tonelli, Hector Cajigas, Stephen C Mathai, Sandeep Sahay
Published: 202510.1016/j.chest.2025.11.035
Abstract
BACKGROUND: Current evidence supports risk-based treatment for pulmonary arterial hypertension (PAH) with an endothelin receptor antagonist and phosphodiesterase type 5 inhibitor as initial therapy for patients with low- and intermediate-risk PAH, an…
Preview only. Read the full abstract at the source